Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000805705 | SCV000945671 | likely pathogenic | Duchenne muscular dystrophy | 2018-11-15 | criteria provided, single submitter | clinical testing | This variant results in a copy number gain of the genomic region encompassing exons 45-55 of the DMD gene. While the exact position of this variant cannot be determined from this data, sub-genic copy number gains are generally in tandem (PMID: 25640679). This variant would be expected to be in-frame, preserving the integrity of the reading frame. A similar duplication of exons 45-55 has been observed in individuals affected with Duchenne muscular dystrophy or Becker muscular dystrophy, and one of these individuals also has a second DMD duplication event (PMID: 16917894). Sub-genic duplication of exons 50-55 has been determined to be pathogenic (PMID: 12111668, 16917894, Invitae). Therefore, duplications that fully encompass that region are also expected to be pathogenic. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |